Observational Study to Evaluate Effect of Thrupas® Capsule on Cardiovascular System
NCT02029560 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 400
Last updated 2018-03-08
Summary
To evaluate effect on cardiovascular system(blood pressure) when Thrupas® capsule is administered every day for 12 weeks in patients with Lower Urinary Tract Symptoms suggestive of Benign Prostatic Hyperplasia
Conditions
- Benign Prostatic Hyperplasia
Sponsors & Collaborators
- lead INDUSTRY
Eligibility
- Min Age
- 50 Years
- Sex
- MALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2013-11-30
- Primary Completion
- 2014-11-30
- Completion
- 2014-11-30
Countries
- South Korea
Study Locations
More Related Trials
-
Study to Compare the Efficacy and Safety of Combination Treatment With Dutasteride and Tamsulosin With Tamsulosin Monotherapy, in Men With Moderate to Severe Benign Prostatic Hyperplasia
NCT02058368 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Evaluate the Efficacy, Safety, and Tolerability of Mirabegron in Men With OAB Symptoms While Taking Tamsulosin Hydrochloride for Lower Urinary Tract Symptoms (LUTS) Due to Benign Prostatic Hyperplasia (BPH)
NCT02757768 ·Status: COMPLETED ·Phase: PHASE4
-
Observational Study of Tamsulosin in Patients With Benign Prostatic Hyperplasia
NCT02245555 ·Status: COMPLETED
-
A Phase 4 Study to Evaluate the Efficacy, Safety, and Tolerability of Mirabegron in Male Subjects With Overactive Bladder (OAB) Symptoms, While Taking the Alpha Blocker for Benign Prostatic Hypertrophy (BPH)
NCT02656173 ·Status: COMPLETED ·Phase: PHASE4
-
Clinical Trial to Evaluate the Efficacy and Safety of Naftopidil in Male Patients With Lower Urinary Tract Symptoms Associated With Benign Prostatic Hyperplasia
NCT01922375 ·Status: COMPLETED ·Phase: PHASE4
-
Clinical Progression and Costs in Benign Prostatic Hyperplasia Patients Treated With Early Versus Delayed Combination Therapy
NCT01435954 ·Status: COMPLETED
-
Medical Therapy of Prostatic Symptoms
NCT00021814 ·Status: COMPLETED ·Phase: PHASE3
-
PK Comparison of GL2701 With Finasteride and Tamsulosin in Combination
NCT01829893 ·Status: COMPLETED ·Phase: PHASE1
-
Effects of Tamsulosin 0.4mg on Clinical Outcomes in Korean Men With Severe Symptomatic Benign Prostatic Hyperplasia (BPH)
NCT01404637 ·Status: UNKNOWN ·Phase: NA
-
Extension Study of GI198745 to Treat Benign Prostatic Hyperplasia
NCT00969072 ·Status: COMPLETED ·Phase: PHASE2
-
An Observational Study of Dutasteride and Alpha-blocker Combination Therapy in Men With Symptomatic Benign Prostatic Hyperplasia and PSA Level Over 4 ng/mL
NCT01351987 ·Status: UNKNOWN
-
Evaluate the Efficacy and Safety of GV1001 in Patients With Benign Prostatic Hyperplasia (BPH)
NCT04032067 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of Naftopidil in Patient With Neurogenic Lower Urinary Tract Dysfunction Not Caused by Benign Prostatic Hyperplasia
NCT02034604 ·Status: COMPLETED ·Phase: PHASE4
-
Prevalence of Bacteriuria, Antibiotic Susceptibility, and Treatment Response in Symptomatic Benign Prostatic Hyperplasia
NCT06520267 ·Status: COMPLETED
-
Investigating Medication vs. Prostatic Urethral Lift: Assessment and Comparison of Therapies for BPH
NCT04987892 ·Status: RECRUITING ·Phase: PHASE4
-
Effects of Chronic Use of Doxazosin in Men With Benign Prostatic Hyperplasia
NCT00730418 ·Status: COMPLETED ·Phase: NA
-
Comparative Bioavailability of Two Fixed Dose Combination (FDC) Formulations of Dutasteride and Tamsulosin Hydrochloride Relative to Co-administration of Dutasteride With Tamsulosin Hydrochloride in Healthy Male Subjects Under Fed and Fasted States
NCT02184585 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluation of PSA Blood Levels Prior to and After Digital Rectal Examination
NCT02747563 ·Status: UNKNOWN ·Phase: PHASE1
-
Prospective Sexual Function Study for BPH Subjects
NCT01777269 ·Status: COMPLETED ·Phase: PHASE4
-
A 6-months Observational Study to Evaluate the Quality of Life of Patients Treated With Phytotherapy or Alpha-blockers for Benign Prostatic Hyperplasia
NCT07144709 ·Status: COMPLETED
-
Study the Effects of Different Doses of UK-369,003 in Men With Lower Urinary Tract Symptoms.
NCT00457457 ·Status: COMPLETED ·Phase: PHASE2
-
A Study Assessing a Range of Formulations of the Fixed Dose Combination Product Containing Dutasteride (0.5mg) and Tamsulosin Hydrochloride (0.2mg) to Find a Formulation Which is Bioequivalent to Harnal-D Tablets (Tamsulosin Hydrochloride, 0.2mg) in Healthy Male Subjects From North East Asia
NCT01495026 ·Status: COMPLETED ·Phase: PHASE1
-
Clinical Evaluation of NX-1207 for the Treatment of Benign Prostatic Hyperplasia (BPH) NX02-0018
NCT00945490 ·Status: COMPLETED ·Phase: PHASE3
-
A Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of HGP0412 and HIP1402 in Patients With BPH
NCT02390882 ·Status: COMPLETED ·Phase: PHASE3
-
A Study To Compare 3 Different Formulations Of Tamsulosin At Steady State.
NCT00609596 ·Status: COMPLETED ·Phase: PHASE1